PRESS RELEASE – December 8, 2010
A Breakthrough for Infertility!
In an extensive clinical study Maitake SX-Fraction demonstrates benefits for those suffering from PCOS
[protected]Polycystic ovary syndrome (PCOS) is one of the most common female endocrine disorders affecting about 5-10% of women of reproductive age, and is believed to be a leading cause of female infertility. An extensive clinical study was conducted in Japan using a proprietary Maitake extract that has confirmed its effect against PCOS. The result has been published recently at The Journal of Alternative and Complementary Medicine, Vol. 16 (Mary Ann Liebert, Inc.).
Eighty (80) patients with PCOS were enrolled in this study conducted at J.T. Chen, Loma Linda, and Sophia Ladies Clinics in Japan over a period of 3 years. The patients were randomly assigned to receive either Maitake SX-fraction (MSX), US Patent #7,214,778, or clomiphene citrate (CC), known as Clomid, for up to 12 weeks. As a result, 20 (out of 26) patients in the MSX group and 29 (out of 31) patients in the CC group showed ovulation. Also, 6 patients ( out of 8 ) who failed in CC therapy showed ovulation when using a combined therapy of CC and MSX. This result suggests that MSX alone may induce ovulation in PCOS patients and may be very useful for those people where CC treatment failed.
CC is a drug commonly used as a first-line treatment to PCOS patients. It is usually well-tolerated for most of people, but may have side effects such as hot flashes, abdominal discomfort, weight gain, mood swings, nausea and dizziness, etc. as well as increasing the likelihood of delivering twins or multiple pregnancies. Another potential side effect is thick cervical mucus, which may lead to a decreased chance of getting pregnant.
In this study, 3 of the 26 patients in the MSX group wished to be pregnant and all 3 conceived after the MSX treatment or a combination of both MSX and CC. None of the CC group that wanted to conceive did. No significant adverse side effects have been reported for MSX over the 8 years that it has been on the market.
MSX has now demonstrated significant clinical benefits as a safe and reliable remedy for those who are suffering from infertility associated with PCOS. For more information on Maitake SX-Fraction product or raw material, please contact Mushroom Wisdom at 800-747-7418.